Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Ryan, J. M.
* Articles by Tariot, P. N.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Ryan, J. M.
* Articles by Tariot, P. N.
Related Collections
* Geriatric Psychiatry
* Community Residential Facilities
* Health Policy and Legislation
* Anticonvulsants
* Antidepressants
* Atypical Neuroleptics
* Conventional Neuroleptics
Psychiatr Serv 53:1407-1413, November 2002
© 2002 American Psychiatric Association


Special Section on Long-Term Care

Mental Health Services in Nursing Homes: Psychopharmacologic Interventions in Nursing Homes: What Do We Know and Where Should We Go?

J. Michael Ryan, M.D., Samuel W. Kidder, Pharm.D., M.P.H., Lori A. Daiello, Pharm.D. and Pierre N. Tariot, M.D.

Psychiatric symptoms are common among individuals who live in nursing homes, with prevalence rates ranging from 51 percent to 94 percent. Accordingly, psychotropic medications are widely prescribed in this setting and are the subject of considerable debate and regulation. Current regulations arose from public and governmental concerns that psychiatric medications were being prescribed inappropriately to frail patients. Concern has also been raised about the absence of evidence on which to base prescribing decisions. Nursing homes are slowly being recognized as complex health care settings that warrant considerable research attention. This article explores the origins of the regulation of the use of psychotropic drugs in nursing homes, reviews controlled trials of these drugs in nursing homes, examines the role of these agents in adverse drug events experienced by nursing home residents, and proposes policy and research areas that merit consideration.




This article has been cited by other articles:


Home page
AJGPHome page
P. G. Walsh, G. Currier, M. N. Shah, J. M. Lyness, and B. Friedman
Psychiatric Emergency Services for the U.S. Elderly: 2008 and Beyond
Am J Geriatr Psychiatry, September 1, 2008; 16(9): 706 - 717.
[Abstract] [Full Text] [PDF]


Home page
Journal of Applied GerontologyHome page
N. G. Castle and J. B. Engberg
Nursing Home Deficiency Citations for Medication Use
Journal of Applied Gerontology, April 1, 2007; 26(2): 208 - 232.
[Abstract] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
K. M. Simpson, K. C. Richards, C. A. Enderlin, P. S. O'Sullivan, and M. Koehn
Medications and Sleep in Nursing Home Residents With Dementia
Journal of the American Psychiatric Nurses Association, October 1, 2006; 12(5): 279 - 285.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org